Everything about Lu

🧭 Start here: a 6-step reading path

1. Read the overview: LuA 5-minute orientation
2. Skim a recent paper: [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 studyInfluential work since 2022
3. Pick up a classic book: 沈阳铁路局志稿The most-reprinted book on the subject
4. Read the landmark paper: THREE NATURAL ZIRCON STANDARDS FOR U‐TH‐PB, LU‐HF, TRACE ELEMENT AND REE ANALYSESCited 5,815 times
5. Go sideways: TanA closely related topic
6. Go sideways: JiA closely related topic

🏆 Landmark papers (most cited)

• THREE NATURAL ZIRCON STANDARDS FOR U‐TH‐PB, LU‐HF, TRACE ELEMENT AND REE ANALYSES

  M. WIEDENBECK, P. ALLÉ, F. CORFU · 1995 · Geostandards Newsletter · 5,815 citations

• Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors

  Jonathan Strosberg, Ghassan El-Haddad, Edward Wolin · 2017 · New England Journal of Medicine · 3,150 citations

• The Lu-Hf isotope geochemistry of chondrites and the evolution of the mantle-crust system

  Janne Blichert-Toft, Francis Albarède · 1997 · Earth and Planetary Science Letters · 2,970 citations

• The Lu–Hf and Sm–Nd isotopic composition of CHUR: Constraints from unequilibrated chondrites and implications for the bulk composition of terrestrial planets

  Audrey Bouvier, Jeffrey D. Vervoort, P. Jonathan Patchett · 2008 · Earth and Planetary Science Letters · 2,942 citations

• The 176Lu decay constant determined by Lu–Hf and U–Pb isotope systematics of Precambrian mafic intrusions

  Ulf Söderlund, P.Jonathan Patchett, Jeffrey D Vervoort · 2004 · Earth and Planetary Science Letters · 2,539 citations

• Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival

  Dik J. Kwekkeboom, Wouter W. de Herder, Boen L. Kam · 2008 · Journal of Clinical Oncology · 1,277 citations

• [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

  Michael S Hofman, Louise Emmett, Shahneen Sandhu · 2021 · The Lancet · 1,126 citations

• Relationships between Lu–Hf and Sm–Nd isotopic systems in the global sedimentary system

  Jeff D Vervoort, P.Jonathan Patchett, Janne Blichert-Toft · 1999 · Earth and Planetary Science Letters · 1,022 citations

🆕 Influential since 2022

• [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study

  Simron Singh, Daniel Halperin, Sten Myrehaug · 2024 · The Lancet · 419 citations

• [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer

  Ute Hennrich, Matthias Eder · 2022 · Pharmaceuticals · 326 citations

• PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial

  James P Buteau, Andrew J Martin, Louise Emmett · 2022 · The Lancet Oncology · 302 citations

• FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer

  Jaleh Fallah, Sundeep Agrawal, Haley Gittleman · 2022 · Clinical Cancer Research · 247 citations

• Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

  Michael S Hofman, Louise Emmett, Shahneen Sandhu · 2024 · The Lancet Oncology · 235 citations

📚 Books worth reading

• 📕沈阳铁路局志稿Shenyang tie lu ju zhi bian zuan wei yuan hui · 1988
• Chao hua xi shiLu Xun, Shixiong Qiu · 1979
• Heating, ventilating, and air conditioningFaye C. McQuiston, Jerald D. Parker · 1977
• Ah Q and othersLu Xun, Shu-Jen Chou · 1941
• Zhao hua xi shiLu Xun · 1960
• 📕鹿港鎭志Xueji Xu, 鹿港鎭志纂修委員會 · 1998
• Zhao hua xi shiLu Xun · 2007
• 📕Tang Ming lü he bianYunsheng Xue · 1968

Ranked by number of editions on Open Library, a rough measure of how lasting a book is.

🔗 Related topics

• Tan Look up tan or TAN in Wiktionary, the free dictionary. Tan or TAN may refer to: Tangent function, a trigonometric function often referred to as tan. Tan…
• Ji Look up ji, Ji, or JI in Wiktionary, the free dictionary. Ji may refer to: Ji (surname), the pinyin romanization of several distinct Chinese surnames Ji…
• Yi Look up Yi, yi, yì, yí, or yī in Wiktionary, the free dictionary. Yi or YI may refer to: Yi (philosophy) (义; 義, righteousness, justice) among the Three…
• Shan Look up shan in Wiktionary, the free dictionary. Shan may refer to: Shan (surname), or 单 in Chinese, a Chinese surname Shan, a variant of the Welsh given…
• Fei (surname) Fei (simplified Chinese: 费; traditional Chinese: 費; pinyin: Fèi) is a traditional Chinese surname. It was 65th in the Hundred Family Surnames. This surname…
• Zou (state) Zou (simplified Chinese: 邹; traditional Chinese: 鄒), originally Zhu (邾) or Zhulou (邾婁), was a minor state that existed during the Zhou dynasty of ancient…
• Han Look up Han or han in Wiktionary, the free dictionary. Han or HAN may refer to: Han Chinese, or Han people (simplified Chinese: 汉人; traditional Chinese:…
• Min Look up MIN, Min, min, -min, or min. in Wiktionary, the free dictionary. Min or MIN may refer to: Fujian, also called Mǐn, a province of China Min Kingdom…